Remarkably, addition of DuAb and EDuAb could induce the activation of T cells derived from ALL patients, shown by upregulation of activation markers CD69, CD25, the degranulation marker CD107a, and the production of IL-2, TNF-α and IFN-γ (Fig. 5a, b). The gene discussed is IL2; the disease is acute lymphoblastic leukemia.